InvestorsHub Logo
Followers 609
Posts 26743
Boards Moderated 1
Alias Born 08/12/2010

Re: ajd post# 23265

Saturday, 11/18/2017 11:15:33 AM

Saturday, November 18, 2017 11:15:33 AM

Post# of 64394
I think it sounds like a great idea....

How to promote, run a tv commercial in the Washington DC area only.



Its my understanding Rik has consultants already working with the various state, federal, and health industry decision makers to introduce Nyloxin and share the results and its viability as an alternative to opioid's.

Rik had mentioned in his email stickied above that they are working with the government and VA. I can't help but think some of the joint ventures he also discussed could include not only the FDA Orphan Drug Status Phase II trials but also getting Nyloxin out there as an alternative to opioid's.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136051474

I believe Brewer and his group could be involved with this exposure as well. He has contacts with pharma and biotech. He has a personal connection to this as well. He deals with pain from his days in Pro Football. That translates into passion and he has many friends dealing with the same conditions.

I am with you, possibly a media target like DC could get the Nyloxin alternative in front of some more eyes. Great idea. Its all about awareness. The opioid crisis is getting more and more coverage every day!!! Now we need a way to connect the dots!!! I believe those dots are getting connected as we speak.

Sitting at 1.3 million market cap with all that is in the pipeline NPHC is way undervalued. 20-30 million is conservative today. Phase II FDA trials kick into high gear Rik stated comparatively to other bio's the market cap is worthy of 100 million (.05 PPS). Conservatively I would take 60 million (.03 PPS). This doesn't include the opioid crisis alternative which is heating up by the day. In all reality the opioid alternative could generate a much higher Market Cap in comparison than the FDA Phase II trials. Think about that for a moment.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133351752

I am with you on opioid's destruction. We have friends and friends of friends that have had arthritis, an injury or surgery and used pain killers only to become addicted. I believe I read 68,000 lives are lost annually related to opioid's. That's amazing considering it's while one group is rolling in profits knowing exactly the issues the opioid's create.

Many folks are in a way that they need the pain killing effect for the rest of their lives. Its not an option to drop off pain killers. Well folks there is an option we know about and its powerful, its not an opiate, its not addictive, it has no side effects,and its non narcotic. My question is why hasn't big pharma been searching for and using something like this all along??? Unfortunately we know why.

Timing is everything and I do believe Nutra Pharma's time is about to arrive. Opportunities like this sometimes only come once in a lifetime. If NPHC gets a fraction of a percent. Yes a fraction of 1 percent of the opioid market today that translates to massive growth. What if, just what if, Nyloxin becomes a larger player than a fraction of 1 percent, like 1 or 2 percent. Thats scary!!!


Cache mentioned another stock last year that ran to a 300 million cap market cap and they at the time were just hoping to get Orphan Drug Status. We are so much bigger than that its not even close. We not only already have Orphan Drug Status we are headed to FDA Phase II trials, we have an opioid alternative, we have 21 patents, and we have 10 drugs in our pipeline not to mention many other catalysts.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134731789


Well, let's see... OWC* ran to over $300M market cap on possible orphan drug status with no clinical trials, product, or

revs at the time. We already have a celebrity endorsement on one of our existing products and awaiting Phase II study news, so....



A 300 million market cap for NPHC would represent a PPS of .16.

I've seen it happen as many have.

There are no guarantees in pinky land but the facts and events are continuing to grow in their favor. Now its up to management to get it done!!! I think they are diligently working on it and will get it done.

The time remaining in 2017 and 2018 could be huge for Nutra Pharma!!!

Have a great weekend folks!!!


ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!